Michael Campbell, MD | oneGRAVESvoice

welcome to oneGRAVESvoice

- a positively charged Graves' disease and thyroid eye disease community.
  • join today!
Healthcare Professionals

Michael Campbell, MD

Healthcare Professional
Associate Professor
UC Davis Comprehensive Cancer Center
4501 X Street, 2nd Floor
Sacramento, California, United States

Michael Campbell is a fellowship-trained endocrine surgeon who specializes in the surgical treatment of patients with thyroid, parathyroid, adrenal and pancreatic disorders. He is an expert in minimally invasive parathyroid and thyroid surgery as well as complex laparoscopic adrenal surgery. He offers a wide range of unique services including transabdominal laparoscopic adrenalectomy, minimally invasive and reoperative thyroid and parathyroid surgery, lymph node dissection using blue dye localization and ethanol ablation of recurrent thyroid cancer.

Dr. Campbell’s research interests include improving multidisciplinary care for endocrine patients, patient outcomes following thyroid surgery, recurrent and persistent hyperparathyroidism, and familial endocrine disorders (such as multiple endocrine neoplasia).

Michael Campbell recently joined UC Davis Health System as its first fellowship-trained endocrine surgeon. He comes to UC Davis following his fellowship training at UC San Francisco Helen Diller Family Comprehensive Cancer Center and residency training at Virginia Mason Medical Center in Seattle. He chose to specialize in endocrine surgery because of the mix of intricate decision making and the challenging operations it involves.

In addition to goiters, Dr. Campbell specializes in the evaluation and management of thyroid nodules, thyroid cancer, Graves’ disease, hyperparathyroidism, adrenal tumors (such as adrenal cortical cancer, pheochromocytomas, aldosteronomas and Cushing’s syndrome) and endocrine tumors of the pancreas. 

 

Representative Publications:

Both Ultrasound Features and Nuclear Atypia are Associated With Malignancy in Thyroid Nodules With Atypia of Undetermined Significance

Vandetanib and the Management of Advanced Medullary Thyroid Cancer

A Multi-Institutional International Study of Risk Factors for Hematoma After Thyroidectomy

Unanticipated Thyroid Cancer in Patients With Substernal Goiters: Are we Underestimating the Risk?

Font Resize

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close